Vimarsana
Biggest News Aggregation in the World

Page 32 - Controlled Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Controlled Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Controlled Trials Today - Breaking & Trending Today

Comparative effect of physical exercise versus statins on improving arterial stiffness in patients with high cardiometabolic risk: A network meta-analysis - Vimarsana News

Comparative effect of physical exercise versus statins on improving arterial stiffness in patients with high cardiometabolic risk: A network meta-analysis

Research Article Comparative effect of physical exercise versus statins on improving arterial stiffness in patients with high cardiometabolic risk: A network meta-analysis Iván Cavero-Redondo, Affiliation Universidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain Affiliation Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom ⨯ Celia Alvarez-Bueno , Affiliation Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom Affiliation Universidad de Castilla-La Mancha, Health a...

Source: plos.org
Ivermectin is effective for COVID-19: real-time meta analysis of 35 studies - Vimarsana News

Ivermectin is effective for COVID-19: real-time meta analysis of 35 studies

Ivermectin is effective for COVID-19: real-time meta analysis of 35 studies Posted on •100% of the 35 studies to date report positive effects. Early treatment is more successful, with an estimated reduction of 84% in the effect measured using a random effects meta-analysis, RR 0.16 [0.08-0.33]. Prophylactic use also shows high effectiveness. •100% of the 17 Randomized Controlled Trials (RCTs) report positive effects, with an estimated reduction of 71%, RR 0.29 [0.17-0.51]. •The probability that an ineffective treatment generated results as positive as the 35 studies to date is estimat...

Dr. Daniel Kopans: Will the USPSTF heed science on breast screening? - Vimarsana News

Dr. Daniel Kopans: Will the USPSTF heed science on breast screening?

Dr. Daniel Kopans. The history of the U.S. Preventive Services Task Force (USPSTF) on breast screening is another case in point, in which decisions on mammography guidelines have been based on flawed analyses of scientific data. When the USPSTF last week opened a new review of breast screening guidelines, it created the opportunity to revisit the group's flawed decision in 2009 to not recommend breast screening for women in their 40s. However, a number of factors need to be addressed for the 2021 review to present a fair and impartial review of the science and evidence in favor of breast sc...